Comparison of Macular Pigment Optical Density in Glaucoma Patients and Healthy Subjects – A Prospective Diagnostic Study
Open Access
- 1 April 2020
- journal article
- research article
- Published by Taylor & Francis Ltd in Clinical Ophthalmology
- Vol. ume 14, 1011-1017
- https://doi.org/10.2147/OPTH.S224259
Abstract
Purpose: To evaluate the relationship between macular pigment optical density (MPOD) and glaucoma. Methods: Forty-three patients with an established glaucoma diagnosis (25 females, 18 males, mean age 70 (range 34– 84)) and 43 healthy controls (28 females, 15 males, mean age 62 (range 30– 87)) were included in this prospective diagnostic case-control study. All subjects underwent detailed eye examination including ophthalmoscopy, best-corrected visual acuity, biomicroscopy, measurement of the axial length of the eye, objective refraction, lens status, central foveal thickness on spectral-domain optical coherence tomography (SD-OCT). In all glaucoma patients, a visual field assessment and a measurement of the retinal nerve fibre layer (RNFL) on SD-OCT were done. MPOD was determined using the macula pigment module of the Spectralis HRA+OCT (Heidelberg Engineering GmbH, Heidelberg, Germany) at 0.51°, 1.02° and 1.99° retinal eccentricity using two-wavelength autofluorescence imaging. Results: In the glaucoma group, the median of the visual field mean defect was 5.1 db (quartiles 3.0 and 13.5) and the mean RNFL-thickness global was 65.9 μm (SD ± 16.1). Median MPOD measured at 0.51°, 1.02° and 1.99° retinal eccentricity in the glaucoma group was 0.42 DU, 0.34 DU and 0.13 DU, in the control group 0.40 DU, 0.35 DU and 0.12 DU respectively. There was no statistically significant difference of median MPOD between glaucomatous and control eyes (p=0.510, 0.735, 0.481). No significant relation between MPOD at 1.02 retinal eccentricity and the presence of glare symptoms was found (p=0.948). However, age seems to correlate with median MPOD measured at 1.02 retinal eccentricity (p=0.017). Conclusion: There was no evidence for lower MPOD levels in our glaucoma patients; lower MPOD was not related to the presence of glare symptoms. However there seems to be a positive correlation between age and MPOD at 1.02° retinal eccentricity. To further investigate the relation between glare reported by glaucoma patients and glare disability linked to lower MPOD levels, additional studies are necessary that include both detailed inquiry of the quality of glare and a glare quantification and precise analysis of MPOD levels in glaucoma patients.Keywords
This publication has 31 references indexed in Scilit:
- Evidence of lower macular pigment optical density in chronic open angle glaucomaBritish Journal of Ophthalmology, 2013
- MACULAR TELANGIECTASIARetina, 2010
- Augmentation of Macular Pigment Following Supplementation with All Three Macular Carotenoids: An Exploratory StudyCurrent Eye Research, 2010
- The Glare Hypothesis of Macular Pigment FunctionOptometry and Vision Science, 2007
- Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: The LUNA studyExperimental Eye Research, 2007
- Glaucoma as a neurodegenerative diseaseCurrent Opinion in Opthalmology, 2007
- The number of people with glaucoma worldwide in 2010 and 2020British Journal of Ophthalmology, 2006
- Lutein and Zeaxanthin in the Eyes, Serum and Diet of Human SubjectsExperimental Eye Research, 2000
- Patients' perception of visual impairment in glaucoma: a pilot studyBritish Journal of Ophthalmology, 1999